KineticVet Announces Availability of RE-COVR™
For Immediate Release May 24, 2022 RE-COVR™ (Tripelennamine Hydrochloride Injection) Lexington, KY—RE-COVR™ KineticVet announces FDA approval of RE-COVR™ (tripelennamine hydrochloride injection), NADA # 006-417, supplied as a sterile solution in multiple dose vials (250 mL) containing 20 mg per mL. RE-COVR™ is an injectable antihistamine indicated for use in cattle (beef & dairy) and horses. […]
